Navigation Links
Inflammation in body fat is not only pernicious

It has been a common opinion that inflammation in adipose tissue may cause insulin resistance, and thereby type 2 diabetes. However, recent research from the Swedish medical university Karolinska Institutet, published in the New England Journal of Medicine, question the theory that inflammation in the body fat is only pernicious. Instead the findings suggest that a certain form of body fat inflammation is necessary for fat cell turnover in the lean, healthy state.

In 2008 the same group of researchers showed that adult humans constantly produce new fat cells to replace equally rapid break down of the already existing fat cells due to cell death, and that overweight people generate and replace more fat cells than do lean. It is also well established that obesity is a very strong risk factor for the most common form of diabetes (type 2). The mechanisms linking obesity to diabetes are not clear, but it is believed that disturbances in the function of adipose tissue which are induced by obesity impair the action of insulin on carbohydrate and lipid metabolism (insulin resistance) thereby causing type 2 diabetes.

One of the most investigated pathogenic factors behind the link between insulin resistance and obesity is inflammation of adipose tissue (i.e. where the body fat is stored). Adipose inflammation is pronounced among obese and even more so when obesity is accompanied by type 2 diabetes.

"The hypothesis has been that inflammation in adipose tissue indirectly causes insulin resistance and thereby type 2 diabetes", says Professor Peter Arner, who led the study. "However, when we investigated adipose tissue from healthy and lean young women, we found that inflammation also is necessary for fat cell turnover in the lean, healthy state."

The researchers determined the expression of a number of inflammatory factors produced by the adipose tissue. The most important of these factors in adipose tissue is the signal protein TNF-alpha. This so called cytokine influences the generation, growth and death of fat cells in the body (adipocyte turnover) and also inhibits insulin action thereby causing insulin resistance. The researchers also observed a very strong relationship between, on the one hand, the ability of adipose tissue to produce and secrete TNF-alpha and, on the other hand, the size and number of fat cells in the adipose tissue among the healthy, lean women.

"This observation was only made for TNF-alpha, since there was no relationship between other inflammatory factors and adipocytes size or number", says Professor Arner. "Furthermore, the relationship was not found in obese women who were investigated at the same time as the lean ones."

Professor Arner and his group will now continue their search for how TNF-alpha and other factors regulate the regeneration and break down of fat cells, with the goal to find new targets in adipose tissue for medical treatment of type 2 diabetes.


Contact: Katarina Sternudd
Karolinska Institutet

Related biology news :

1. Vaccine could delay bowel inflammation and colon cancer, says Pitt research
2. Could regulating intestinal inflammation prevent colon cancer?
3. Preventing or reversing inflammation after heart attack, stroke may require 2-pronged approach
4. Inflammation on switch also serves as off switch
5. Discovery points toward anti-inflammation treatment for blinding disease
6. New pathway discovered that may prevent tissue damage resulting from inflammation
7. Discovery of new type of immune cells regulating inflammation in chronic diseases
8. Pitt study finds molecular link between insulin resistance and inflammation
9. New trigger for chronic inflammation in rheumatoid arthritis discovered
10. Key protein regulating inflammation may prove relevant to controlling sepsis
11. Vitamin D deficiency related to increased inflammation in healthy women
Post Your Comments:
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... discussion at the Piper Jaffray 27th Annual Healthcare Conference ... is scheduled for Wednesday, December 2, at 8:00 a.m. ... will be available for 14 days after the event.  ... Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... , Nov. 24, 2015 Cepheid (NASDAQ: ... speaking at the following conference, and invited investors to ... NY      Tuesday, December 1, 2015 at 11.00 ... NY      Tuesday, December 1, 2015 at 11.00 ... Conference, New York, NY      Tuesday, ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , ... Annual Healthcare Conference in New York City ... (1:30 p.m. GMT). --> SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> Shire ...
Breaking Biology Technology: